Published in Neurology on February 08, 2011
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol (2016) 1.73
Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain (2011) 1.68
Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab (2012) 1.62
Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J Magn Reson Imaging (2014) 1.16
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol (2015) 1.04
Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis Optica. Mult Scler Int (2013) 1.03
Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging. Mult Scler (2013) 1.00
Ultrahigh-field MRI in human ischemic stroke--a 7 tesla study. PLoS One (2012) 0.97
Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysis. BMC Med (2013) 0.94
Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis. Mult Scler (2014) 0.91
Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning--an ultrahigh-field MR pilot study. Eur Radiol (2014) 0.90
Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla. Eur Radiol (2013) 0.88
Nonconventional MRI and microstructural cerebral changes in multiple sclerosis. Nat Rev Neurol (2015) 0.87
Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management. EPMA J (2015) 0.86
Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. JAMA Neurol (2015) 0.86
Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions. Mult Scler (2013) 0.85
"Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine. Ann Clin Transl Neurol (2015) 0.83
Current and new directions in MRI in multiple sclerosis. Continuum (Minneap Minn) (2013) 0.82
7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study. Neurol Neuroimmunol Neuroinflamm (2015) 0.80
Venocentric Lesions: An MRI Marker of MS? Front Neurol (2013) 0.79
On the role of physiological fluctuations in quantitative gradient echo MRI: implications for GEPCI, QSM, and SWI. Magn Reson Med (2014) 0.79
Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010. Int J MS Care (2012) 0.79
Imaging as an Outcome Measure in Multiple Sclerosis. Neurotherapeutics (2016) 0.79
Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI. Neurol Neuroimmunol Neuroinflamm (2016) 0.79
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol (2016) 0.79
Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics. J Neurol (2014) 0.78
High-field imaging of neurodegenerative diseases. Neuroimaging Clin N Am (2012) 0.77
Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration. PLoS One (2015) 0.77
Advanced MRI and staging of multiple sclerosis lesions. Nat Rev Neurol (2016) 0.77
Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis. Mult Scler (2016) 0.76
Pain and spinal cord imaging measures in children with demyelinating disease. Neuroimage Clin (2015) 0.76
Spring cleaning: time to rethink imaging research lines in MS? J Neurol (2016) 0.75
Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members. JAMA Neurol (2017) 0.75
Multiple sclerosis: sun exposure and vitamin D, ultra-high-field imaging, and B cell clones in the meninges. J Neurol (2011) 0.75
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol (2005) 24.22
Stereotaxic display of brain lesions. Behav Neurol (2000) 9.20
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med (2008) 6.86
Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology (1993) 5.72
The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain (1987) 3.15
The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology (1997) 2.31
Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology (1988) 2.03
Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology (2008) 1.50
A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol (2009) 1.46
Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain (1991) 1.26
Assessment of MRI criteria for a diagnosis of MS. Neurology (1993) 1.17
Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis? Neuroradiology (2010) 1.09
Silent lacunar infarction on magnetic resonance imaging (MRI): risk factors. J Neurol Sci (1998) 1.01
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem (1998) 17.36
Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal Biochem (1991) 16.18
The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res (2005) 12.94
BIND--The Biomolecular Interaction Network Database. Nucleic Acids Res (2001) 11.74
Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg (1995) 9.02
Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc Natl Acad Sci U S A (2000) 9.02
KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science (1998) 7.32
Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity. Cell (2000) 6.92
Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell (1999) 6.59
Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science (1990) 5.21
Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc Natl Acad Sci U S A (1991) 4.57
Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science (2000) 4.22
PTEN and myotubularin: novel phosphoinositide phosphatases. Annu Rev Biochem (2001) 3.78
Components of a new human protein kinase signal transduction pathway. J Biol Chem (1995) 3.78
PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol (1999) 3.62
Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol (1996) 3.50
A Tyr/Ser protein phosphatase encoded by vaccinia virus. Nature (1991) 3.35
Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 A and the complex with tungstate. Nature (1994) 3.10
Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science (1999) 2.78
IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J Immunol (2000) 2.76
A nuclear magnetic resonance study of metabolism in the ferret heart during hypoxia and inhibition of glycolysis. J Physiol (1985) 2.73
Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. J Biol Chem (1991) 2.72
A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci U S A (2001) 2.61
Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc Natl Acad Sci U S A (2000) 2.59
Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ Res (1999) 2.47
Protein tyrosine phosphatases. Annu Rev Biochem (1993) 2.37
Regulation of KChIP2 potassium channel beta subunit gene expression underlies the gradient of transient outward current in canine and human ventricle. J Physiol (2001) 2.37
New vectors for high level expression of recombinant proteins in bacteria. Anal Biochem (1992) 2.34
Spatial and temporal mapping of neural activity associated with auditory hallucinations. Lancet (1999) 2.31
Crystal structure of the dual specificity protein phosphatase VHR. Science (1996) 2.28
A sodium channel signaling complex: modulation by associated receptor protein tyrosine phosphatase beta. Nat Neurosci (2000) 2.25
Automatic annotation of BIND molecular interactions from three-dimensional structures. Biopolymers (2002) 2.24
RNA interference of gene expression (RNAi) in cultured Drosophila cells. Sci STKE (2001) 2.14
De novo purine nucleotide biosynthesis. Prog Nucleic Acid Res Mol Biol (1992) 2.11
Form and function in protein dephosphorylation. Cell (1996) 2.09
Cloning and expression of a protein-tyrosine-phosphatase. Proc Natl Acad Sci U S A (1990) 2.07
Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Curr Opin Chem Biol (1998) 2.06
The Yersinia tyrosine phosphatase: specificity of a bacterial virulence determinant for phosphoproteins in the J774A.1 macrophage. J Exp Med (1992) 2.05
Expression, purification, and physicochemical characterization of a recombinant Yersinia protein tyrosine phosphatase. J Biol Chem (1992) 2.02
The workup for bariatric surgery does not require a routine upper gastrointestinal series. Obes Surg (1997) 1.94
Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol (1998) 1.91
Expression, purification, crystallization, and biochemical characterization of a recombinant protein phosphatase. J Biol Chem (1993) 1.84
Substrate specificity of the protein tyrosine phosphatases. Proc Natl Acad Sci U S A (1993) 1.84
Mutational analysis of a Ser/Thr phosphatase. Identification of residues important in phosphoesterase substrate binding and catalysis. J Biol Chem (1994) 1.83
Crystal structure of a phospholipase D family member. Nat Struct Biol (1999) 1.83
Dissecting the catalytic mechanism of protein-tyrosine phosphatases. Proc Natl Acad Sci U S A (1994) 1.80
Expression of a protein tyrosine phosphatase in normal and v-src-transformed mouse 3T3 fibroblasts. J Cell Biol (1992) 1.80
Climate change and the integrity of science. Science (2010) 1.80
TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J Immunol (1995) 1.80
Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain (2008) 1.79
A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast. J Biol Chem (1997) 1.79
Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol Cell Neurosci (1998) 1.78
Intracellular calcium measurements by 19F NMR of fluorine-labeled chelators. Proc Natl Acad Sci U S A (1983) 1.77
Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle. Diabetes (1995) 1.75
Localization of atrial natriuretic peptide mRNA and immunoreactivity in the rat heart and human atrial appendage. Proc Natl Acad Sci U S A (1987) 1.74
A distinctive role for the Yersinia protein kinase: actin binding, kinase activation, and cytoskeleton disruption. Proc Natl Acad Sci U S A (2000) 1.74
The functional anatomy of auditory hallucinations in schizophrenia. Psychiatry Res (2000) 1.72
A procedure for in situ alkylation of cystine residues on glass fiber prior to protein microsequence analysis. Anal Biochem (1987) 1.70
Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. Proc Natl Acad Sci U S A (1984) 1.70
Primary structure of soybean lipoxygenase-1. J Biol Chem (1987) 1.69
A catalytic mechanism for the dual-specific phosphatases. Proc Natl Acad Sci U S A (1995) 1.68
Biologically active catecholamines covalentyly bound to glass beads. Proc Natl Acad Sci U S A (1972) 1.68
A sensitive assay for phosphoinositide phosphatases. Anal Biochem (2000) 1.64
Primary structure of soybean lipoxygenase L-2. J Biol Chem (1988) 1.62
A method for increasing the sensitivity of chloramphenicol acetyltransferase assays in extracts of transfected cultured cells. Anal Biochem (1987) 1.59
Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis. Proc Natl Acad Sci U S A (1996) 1.58
Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. Proc Natl Acad Sci U S A (1996) 1.57
5-fluorouracil metabolism monitored in vivo by 19F NMR. Br J Cancer (1984) 1.56
Gathering STYX: phosphatase-like form predicts functions for unique protein-interaction domains. Trends Biochem Sci (1998) 1.56
Isolation and characterization of a human dual specificity protein-tyrosine phosphatase gene. J Biol Chem (1994) 1.55
The Cys(X)5Arg catalytic motif in phosphoester hydrolysis. Biochemistry (1994) 1.54
Protein-tyrosine phosphatases. J Biol Chem (1994) 1.54
Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability. J Neurol Neurosurg Psychiatry (2003) 1.53
Active site labeling of the Yersinia protein tyrosine phosphatase: the determination of the pKa of the active site cysteine and the function of the conserved histidine 402. Biochemistry (1993) 1.53
Bromocriptine treatment in Parkinson's disease. J Neurol Neurosurg Psychiatry (1976) 1.50
Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology (2008) 1.50
The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol (2006) 1.50
Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci U S A (1984) 1.49
Identification of two nervous system-specific members of the erg potassium channel gene family. J Neurosci (1997) 1.46
The contribution of demyelination to axonal loss in multiple sclerosis. Brain (2006) 1.46
In vitro activation of the transcription factor ISGF3 by interferon alpha involves a membrane-associated tyrosine phosphatase and tyrosine kinase. J Biol Chem (1993) 1.44
Cloning and structural characterization of porcine heart aconitase. J Biol Chem (1990) 1.44
PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res (1997) 1.43
Differences in the diagnostic accuracy of acute stroke clinical subtypes defined by multimodal magnetic resonance imaging. J Neurol Neurosurg Psychiatry (2003) 1.43
Conserved histidine residues in soybean lipoxygenase: functional consequences of their replacement. Biochemistry (1992) 1.40
Cervical lymphadenopathy in children. Hosp Med (2003) 1.39
Responses of pregnant ewes and young lambs to cold exposure. Can Vet J (1987) 1.38
Cloning and characterization of a mRNA-encoding rat preprosomatostatin. J Biol Chem (1983) 1.37
Alternative splicing gives rise to a nuclear protein tyrosine phosphatase in Drosophila. J Biol Chem (1993) 1.37
Cerebral metabolism of acetate and glucose studied by 13C-n.m.r. spectroscopy. A technique for investigating metabolic compartmentation in the brain. Biochem J (1990) 1.37
Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry (2008) 1.36
Phoxy lipids: revealing PX domains as phosphoinositide binding modules. Cell (2001) 1.36
Hypoglycemia masquerading as cerebrovascular disease (hypoglycemic hemiplegia). Ann Neurol (1985) 1.35
Catalytic mechanism of the phospholipase D superfamily proceeds via a covalent phosphohistidine intermediate. Proc Natl Acad Sci U S A (1998) 1.34
Tissue and species distribution of mRNA for the IKr-like K+ channel, erg. Circ Res (1997) 1.33